Ally Bridge Group


Ally Bridge Group is a global healthcare investment management firm focused on high-impact life science innovation. Founded in 2013 by Frank Yu, the firm manages assets from offices in New York and Hong Kong. Ally Bridge Group has been the lead or co-lead on over $6 billion of transactions across healthcare subsectors. Their mission is to generate superior risk-adjusted returns for investors while addressing unmet medical needs, achieved by blending deep scientific and clinical research with proven M&A and capital markets expertise. They invest across the global healthcare industry through private equity and public equity strategies.

Ally Bridge Group

Ally Bridge Group


Portfolio

Focused on non-invasive solutions for chronic nasal conditions.

#Medical Technology

Aims to develop next-generation genetic medicines using machine learning/AI.

#Biotechnology

Combines AI and machine learning with science to discover effective medicines.

#Drug Discovery

Develops a portable EEG headband for rapid diagnosis of neurological conditions.

#Medical Device

Dedicated to transforming surgery with the Versius surgical robot.

#Medical Devices

Uses electronic health records to ensure patient access to clinical research.

#Health Research

Targets core drivers of terminal diseases to develop best-in-class medicines.

#Precision Medicine

Focuses on solutions for stroke patients with cleared product platforms.

#Medical Technology

Creates patient care solutions using focused ultrasound technology.

#Medical Device

Develops wearable cardioverter defibrillators for cardiac patients.

#Medical Device

Offers personalized 3D printed braces and digital treatment planning.

#Orthodontics

Engaged in R&D, manufacturing, and sale of chemical medicine.

#Pharmaceuticals

Focuses on neurostimulation systems for chronic low back pain.

#Medical Device

Develops technology for in-office dental treatments.

#Dental Technology

Provides in-clinic pharmacy services with robotic dispensing.

#Pharmacy Technology

Focuses on single cell genomics and multi-omics solutions.

#Life Science Tools

Develops novel antibody-based therapeutics for cancer.

#Biotechnology

Provides minimally invasive treatments for severe lung disease.

#Medical Technology

Develops solutions for minimally invasive liver cancer treatment.

#Medical Robotics

Provides automated microbial quality control solutions.

#Pharmaceutical Manufacturing

Develops biology-guided radiotherapy systems for cancer treatment.

#Medical Technology

Develops iPSC-derived immunotherapies for cancer treatment.

#Biotechnology

Focuses on Treg cell therapies for autoimmune diseases.

#Biotechnology

Uses real-world evidence to improve cancer patient outcomes.

#Health Technology

Focuses on employee health benefits and healthcare system efficiency.

#Digital Health

Develops technology for chronic disease and mental health management.

#Digital Health

Focuses on wearable biosensor technology for patient monitoring.

#Medical Technology

Provides R&D and manufacturing services for healthcare industries.

#Pharmaceutical Services

Offers end-to-end solutions for biologics development and manufacturing.

#Biologics Technology

Develops next-generation solutions for the treatment of venous reflux disease.

#Medical Technology


Key People

Founder, Chief Executive Officer, Chief Investment Officer

Chief Financial Officer, Public Equity

Executive Coordinator

Executive Coordinator

Finance Manager, Private Equity

Head of Operations, Public Equity